Broadridge director reports new equity grants in Form 4 filing

Rhea-AI Filing Summary

Broadridge Financial Solutions (BR) reported an equity award to one of its directors. On 11/13/2025, the director received 459 Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, representing the same number of shares of common stock. These units vest in full upon grant and will be settled in shares of Broadridge common stock when the director separates from service. The filing also shows a grant of 1,758 stock options with an exercise price of $225.61 per share, which vest immediately and expire on 11/13/2035. Following the stock unit grant, the director directly owns 2,649 shares of Broadridge common stock, in addition to the stock options.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider FLOWERS MELVIN L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,758	$0.00	--
Grant/Award	Common Stock	459	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,758 shares (Direct); Common Stock — 2,649 shares (Direct)

Footnotes (1)

1. The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Stock options vest immediately upon grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLOWERS MELVIN L

(Last) (First) (Middle)

5 DAKOTA DRIVE

(Street)

LAKE SUCCESS NY 11042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADRIDGE FINANCIAL SOLUTIONS, INC. [ BR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		459	A	$0.0000(1)	2,649	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$225.61	11/13/2025		A		1,758		11/13/2025(2)	11/13/2035	Common Stock	1,758	$0.0000	1,758	D

Explanation of Responses:

1. The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

2. Stock options vest immediately upon grant.

	Maria Allen, Power of Attorney	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Broadridge (BR) report in this Form 4?

The filing reports that a director of Broadridge Financial Solutions (BR) received equity awards on 11/13/2025, including Deferred Stock Units and stock options under the company’s 2018 Omnibus Award Plan.

How many Deferred Stock Units were granted to the Broadridge (BR) director?

The director received 459 Deferred Stock Units, which represent a like number of shares of Broadridge common stock. These units vest in full upon grant and will settle in shares when the director separates from service.

What stock options were granted to the Broadridge (BR) director and at what price?

The director was granted 1,758 stock options with an exercise price of $225.61 per share. The options vest immediately upon grant and are exercisable for Broadridge common stock.

When do the Broadridge (BR) director’s stock options expire?

The stock options granted to the director on 11/13/2025 have an expiration date of 11/13/2035, giving a 10-year term from the grant date.

How many Broadridge (BR) shares does the director own after the reported transaction?

After the reported grant of Deferred Stock Units, the director beneficially owns 2,649 shares of Broadridge common stock directly, as well as 1,758 stock options.

Do the Deferred Stock Units granted by Broadridge (BR) vest over time or immediately?

The 459 Deferred Stock Units granted to the director vest in full upon grant. They will be settled in shares of Broadridge common stock when the director separates from service with the company.